Home Tags Immunotherapy
A study published in Nature Medicine claims that the manipulation of the gut microbiota could be a new strategy to treat toxicity to combined immunotherapy.
Some gut microbial metabolites boost the efficacy of antitumor drugs by regulating the body’s immune response and could be used as a part of cancer therapy.
Researchers have created a catalog of the bacteria associated with all the cancer types. The findings could help to enhance the actions of anticancer drugs.
The modulation of the microbiota impacts on the efficacy of the new anti-PD-1 cancer therapies. We discuss it with Giorgio Trinchieri (NIH, USA).
The gut microbiota could boost the activity of immune cells. That's according to a new study published in the journal Immunity.